vs
Apellis Pharmaceuticals, Inc.（APLS）与HELIOS TECHNOLOGIES, INC.（HLIO）财务数据对比。点击上方公司名可切换其他公司
HELIOS TECHNOLOGIES, INC.的季度营收约是Apellis Pharmaceuticals, Inc.的1.1倍（$220.3M vs $199.9M），HELIOS TECHNOLOGIES, INC.净利率更高（4.7% vs -29.5%，领先34.2%），HELIOS TECHNOLOGIES, INC.同比增速更快（13.3% vs -5.9%），HELIOS TECHNOLOGIES, INC.自由现金流更多（$18.6M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 4.6%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
赫利俄斯科技是一家总部位于美国纽约的上市数据分析企业，在运营末期因收购并运营电影订阅服务MoviePass受到广泛关注，该业务最终导致公司破产。
APLS vs HLIO — 直观对比
营收规模更大
HLIO
是对方的1.1倍
$199.9M
营收增速更快
HLIO
高出19.2%
-5.9%
净利率更高
HLIO
高出34.2%
-29.5%
自由现金流更多
HLIO
多$32.9M
$-14.3M
两年增速更快
APLS
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $220.3M |
| 净利润 | $-59.0M | $10.3M |
| 毛利率 | — | 33.1% |
| 营业利润率 | -25.6% | 0.6% |
| 净利率 | -29.5% | 4.7% |
| 营收同比 | -5.9% | 13.3% |
| 净利润同比 | -62.2% | -9.6% |
| 每股收益（稀释后） | $-0.40 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSHLIO
| Q4 25 | $199.9M | — | ||
| Q3 25 | $458.6M | $220.3M | ||
| Q2 25 | $178.5M | $212.5M | ||
| Q1 25 | $166.8M | $195.5M | ||
| Q4 24 | $212.5M | $179.5M | ||
| Q3 24 | $196.8M | $194.5M | ||
| Q2 24 | $199.7M | $219.9M | ||
| Q1 24 | $172.3M | $212.0M |
净利润APLSHLIO
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $10.3M | ||
| Q2 25 | $-42.2M | $11.4M | ||
| Q1 25 | $-92.2M | $7.3M | ||
| Q4 24 | $-36.4M | $4.8M | ||
| Q3 24 | $-57.4M | $11.4M | ||
| Q2 24 | $-37.7M | $13.6M | ||
| Q1 24 | $-66.4M | $9.2M |
毛利率APLSHLIO
| Q4 25 | — | — | ||
| Q3 25 | — | 33.1% | ||
| Q2 25 | — | 31.8% | ||
| Q1 25 | — | 30.6% | ||
| Q4 24 | — | 30.1% | ||
| Q3 24 | — | 31.1% | ||
| Q2 24 | — | 32.1% | ||
| Q1 24 | — | 31.7% |
营业利润率APLSHLIO
| Q4 25 | -25.6% | — | ||
| Q3 25 | 48.7% | 0.6% | ||
| Q2 25 | -18.6% | 10.3% | ||
| Q1 25 | -50.0% | 8.7% | ||
| Q4 24 | -12.3% | 7.4% | ||
| Q3 24 | -24.0% | 11.4% | ||
| Q2 24 | -14.7% | 11.8% | ||
| Q1 24 | -36.0% | 9.6% |
净利率APLSHLIO
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | 4.7% | ||
| Q2 25 | -23.6% | 5.4% | ||
| Q1 25 | -55.3% | 3.7% | ||
| Q4 24 | -17.1% | 2.7% | ||
| Q3 24 | -29.2% | 5.9% | ||
| Q2 24 | -18.9% | 6.2% | ||
| Q1 24 | -38.5% | 4.3% |
每股收益（稀释后）APLSHLIO
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | $0.31 | ||
| Q2 25 | $-0.33 | $0.34 | ||
| Q1 25 | $-0.74 | $0.22 | ||
| Q4 24 | $-0.30 | $0.14 | ||
| Q3 24 | $-0.46 | $0.34 | ||
| Q2 24 | $-0.30 | $0.41 | ||
| Q1 24 | $-0.54 | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $54.9M |
| 总债务越低越好 | — | $420.0M |
| 股东权益账面价值 | $370.1M | $917.9M |
| 总资产 | $1.1B | $1.6B |
| 负债/权益比越低杠杆越低 | — | 0.46× |
8季度趋势，按日历期对齐
现金及短期投资APLSHLIO
| Q4 25 | $466.2M | — | ||
| Q3 25 | $479.2M | $54.9M | ||
| Q2 25 | $370.0M | $53.0M | ||
| Q1 25 | $358.4M | $45.9M | ||
| Q4 24 | $411.3M | $44.1M | ||
| Q3 24 | $396.9M | $46.7M | ||
| Q2 24 | $360.1M | $45.0M | ||
| Q1 24 | $325.9M | $37.3M |
总债务APLSHLIO
| Q4 25 | — | — | ||
| Q3 25 | — | $420.0M | ||
| Q2 25 | — | $437.2M | ||
| Q1 25 | — | $446.7M | ||
| Q4 24 | — | $450.6M | ||
| Q3 24 | — | $484.7M | ||
| Q2 24 | — | $504.0M | ||
| Q1 24 | $93.1M | $521.8M |
股东权益APLSHLIO
| Q4 25 | $370.1M | — | ||
| Q3 25 | $401.2M | $917.9M | ||
| Q2 25 | $156.3M | $911.7M | ||
| Q1 25 | $164.2M | $881.2M | ||
| Q4 24 | $228.5M | $864.4M | ||
| Q3 24 | $237.1M | $885.5M | ||
| Q2 24 | $264.3M | $866.5M | ||
| Q1 24 | $266.7M | $856.6M |
总资产APLSHLIO
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $1.6B | ||
| Q2 25 | $821.4M | $1.6B | ||
| Q1 25 | $807.3M | $1.5B | ||
| Q4 24 | $885.1M | $1.5B | ||
| Q3 24 | $901.9M | $1.6B | ||
| Q2 24 | $904.5M | $1.6B | ||
| Q1 24 | $831.9M | $1.6B |
负债/权益比APLSHLIO
| Q4 25 | — | — | ||
| Q3 25 | — | 0.46× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | 0.51× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.55× | ||
| Q2 24 | — | 0.58× | ||
| Q1 24 | 0.35× | 0.61× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $25.3M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $18.6M |
| 自由现金流率自由现金流/营收 | -7.1% | 8.4% |
| 资本支出强度资本支出/营收 | 0.1% | 3.0% |
| 现金转化率经营现金流/净利润 | — | 2.46× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $91.3M |
8季度趋势，按日历期对齐
经营现金流APLSHLIO
| Q4 25 | $-14.2M | — | ||
| Q3 25 | $108.5M | $25.3M | ||
| Q2 25 | $4.4M | $37.0M | ||
| Q1 25 | $-53.4M | $19.0M | ||
| Q4 24 | $19.4M | $35.7M | ||
| Q3 24 | $34.1M | $34.8M | ||
| Q2 24 | $-8.3M | $33.8M | ||
| Q1 24 | $-133.0M | $17.8M |
自由现金流APLSHLIO
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | $18.6M | ||
| Q2 25 | $4.4M | $31.6M | ||
| Q1 25 | $-53.4M | $12.9M | ||
| Q4 24 | $19.3M | $28.2M | ||
| Q3 24 | — | $28.8M | ||
| Q2 24 | $-8.4M | $25.8M | ||
| Q1 24 | $-133.3M | $12.3M |
自由现金流率APLSHLIO
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | 8.4% | ||
| Q2 25 | 2.5% | 14.9% | ||
| Q1 25 | -32.0% | 6.6% | ||
| Q4 24 | 9.1% | 15.7% | ||
| Q3 24 | — | 14.8% | ||
| Q2 24 | -4.2% | 11.7% | ||
| Q1 24 | -77.3% | 5.8% |
资本支出强度APLSHLIO
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | 3.0% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.0% | 3.1% | ||
| Q4 24 | 0.0% | 4.2% | ||
| Q3 24 | 0.0% | 3.1% | ||
| Q2 24 | 0.0% | 3.6% | ||
| Q1 24 | 0.2% | 2.6% |
现金转化率APLSHLIO
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 2.46× | ||
| Q2 25 | — | 3.25× | ||
| Q1 25 | — | 2.60× | ||
| Q4 24 | — | 7.44× | ||
| Q3 24 | — | 3.05× | ||
| Q2 24 | — | 2.49× | ||
| Q1 24 | — | 1.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
HLIO
| Hydraulics | $141.3M | 64% |
| Electronics | $79.0M | 36% |
